CARLSBAD, CA (PRWEB) AUGUST 17, 2016
Spinal Elements, a spine technology company, announced that they have received 510(k) clearance from the United States Food and Drug Administration (FDA) to market an interspinous process device.
Interspinous process devices are placed between the spinous processes of the spine and provide support and fixation while a spinal fusion forms. The devices can be less disruptive to the spine because minimal muscle and tissue retraction is required to surgically implant them. These characteristics have made the devices attractive in the ambulatory surgical center and outpatient spine markets.
Spinal Elements’ device includes enhancements that make the device more accommodating to patient anatomy while streamlining the surgical procedure. The surgeon will be able to intraoperatively choose the approach that best suits their needs and the needs of their patients. The device may be implanted with minimally-invasive surgical (MIS) techniques or conventional techniques and may be used in superspinous ligament sparing or sacrificing approaches. Whatever the use, the instruments have been optimized and balanced to provide for an accurate and reproducible procedure.
Todd Andres, CEO and co-founder of Spinal Elements, said, “This clearance is another indicator of our relentless pursuit of solutions demanded by our surgeon customers. This device addresses part of our strategy to become the first choice of surgeons in both hospital and outpatient surgery settings.”
The company plans to begin clinical procedures with the interspinous process devices later this year with an initial launch in early 2017.
About Spinal Elements
Spinal Elements, headquartered in Carlsbad, CA, is a spine technology company for spine surgeons who demand innovative, extremely high quality surgical solutions. From the company’s early work which helped make PEEK commonplace throughout the spine industry to recent advancements in Ti-Bond® porous titanium coated PEEK interbody implants and controlled delivery technology, Spinal Elements has built a reputation for being trustworthy, innovative and different. The company is focused on the development and marketing of progressive spinal treatment options and markets a complete portfolio of advanced spinal implant technologies. Additionally, the company distributes Hero® Allograft, the net proceeds from which are donated to charities benefitting children with life-threatening medical conditions. For more information, please visit http://www.spinalelements.com.
